Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Link to Cantor Panel Talk

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Sep 20, 2023 9:27am

120 Views

Post# 35645012

RE:RE:Link to Cantor Panel Talk

Majority of the company's investors don't have access to these presentations so it is definitely worth the cost if they want to update the market, like the companies you mentioned but THTX seems to not getting the point of maximizing the return for their efforts.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects